Gemvax & Kael

This study tested whether regular injections of an experimental drug called GV1001 could help slow the progression of Progressive Supranuclear Palsy (PSP), a rare and serious brain disorder. For 24 weeks, 78 patients in Korea received either one of two doses of GV1001 or a placeb…

This study tested whether weekly injections of an experimental drug called GV1001 could help slow the progression of Alzheimer's disease. It involved 199 people aged 55-85 with mild to moderate Alzheimer's who received either GV1001 or a placebo for one year. The main goal was to…

This study followed patients for an extra year to check the long-term safety and see if the drug GV1001 continued to help control Progressive Supranuclear Palsy (PSP), a rare and serious brain disorder. It involved 67 patients who had already completed a previous trial, giving th…

This was an early-stage study to check the safety and see how the body processes a new drug called GV1001, which is being developed for brain diseases. It involved 59 healthy volunteers who received either the drug or a placebo as a single shot or multiple shots over several week…